Table 1.
Effect of different doses of β-aescin administration on % change in body weight (g) and relative liver weight (g) after CCl4 challenge. Values are expressed as mean ± SD.
| Groups | % change in body weight (g) | Relative liver weight/100g of body weight (g) |
|---|---|---|
| Normal control | 13.25 ± 4.3 | 3.15 ± 0.16 |
| CCl4 control | −26.36 ± −13.02a | 7.26 ± 0.86a |
| Silymarin 50 mg/kg treated | 4.63 ± 9.77b | 3.932 ± 0.49a,b |
| β-Aescin 0.9 mg/kg treated | −10.126 ± 3.51a,b | 5.99 ± 0.52a,b |
| β-Aescin 1.8 mg/kg treated | −5.52 ± 4.36a,b | 5.38 ± 0.32a,b |
| β-Aescin 3.6 mg/kg treated | 4.47 ± 4.19a,b | 3.86 ± 0.36a,b |
a
p < 0.05 as compared with normal control.
b
p < 0.05 as compared with CCl4 control.